Edesa Biotech

EDSA56

Penny Stock

$2.18arrow_drop_up3.31%$0.07

Penny Stock

EDSA56

$2.18

arrow_drop_up3.31%$0.07

Penny Stock

Performance History

Key Stats
Open	$2.08
Prev. Close	$2.11
EPS	-19.78
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$7.04M
PE Ratio	-

	LOW	HIGH
Day Range	2.12	2.27
52 Week Range	1.78	8.33

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-19.78

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Edesa Biotech (EDSA)

Edesa Biotech Inc (EDSA) is a clinical-stage biopharmaceutical company focused on the development of novel treatments for inflammatory and immune-related diseases. The company's pipeline includes several potential therapies targeting dermatological and gastrointestinal conditions, with a particular focus on rare and orphan indications. EDSA is committed to harnessing cutting-edge science and technology to address unmet medical needs and improve patient outcomes.

One of the key areas of interest for Edesa Biotech is the treatment of chronic, non-infectious skin disorders, such as chronic allergic contact dermatitis and chronic hand eczema. These conditions can have a significant impact on patients' quality of life, and there is a need for safe and effective treatment options. EDSA's lead product candidate, EB01, is a novel topical treatment designed to address the underlying inflammation associated with these conditions. The company has completed Phase 2b clinical trials for EB01, and the results have been promising.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Pardeep Nijhawan FRCPC, M.D.
Headquarters: Markham
Employees: 16
Exchange: NASDAQ

Keep an eye on Edesa Biotech

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Edesa Biotech 's (EDSA) price per share?

The current price per share for Edesa Biotech (EDSA) is $2.18. The stock has seen a price change of $0.07 recently, indicating a 3.32% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Edesa Biotech (EDSA)?

For Edesa Biotech (EDSA), the 52-week high is $8.33, which is 282.11% from the current price. The 52-week low is $1.78, the current price is 22.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Edesa Biotech (EDSA) a growth stock?

Edesa Biotech (EDSA) has shown an average price growth of -4.13% over the past three years. It has received a score of 87 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Edesa Biotech as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Edesa Biotech (EDSA) stock price performance year to date (YTD)?

As of the latest data, Edesa Biotech (EDSA) has a year-to-date price change of -53.42%. Over the past month, the stock has experienced a price change of -40.76%. Over the last three months, the change has been -51.01%. Over the past six months, the figure is -51.18%. Looking at a longer horizon, the five-year price change stands at -93.87%.

help

Is Edesa Biotech (EDSA) a profitable company?

Edesa Biotech (EDSA) has a net income of -$8.37M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$9.22M. Furthermore, the EBITDA is -$8.27M.

help

What is the market capitalization of Edesa Biotech (EDSA)?

Edesa Biotech (EDSA) has a market capitalization of $7.05M. The average daily trading volume is 2.17, indicating the stock's liquidity and investor engagement.